Funding

The five-year funding formula for the Ontario Neurodegenerative Disease Research Initiative (ONDRI) includes $19 million from the Ontario Brain Institute (OBI) and $9.5 million in partner (healthcare and academic and research institutions) contributions.

Of the $9.5 million required in partner contributions, over $5 million has currently been raised through philanthropic donations.

ONDRI five-year funding table

2013 2014 2015 2016 2017 Total 
OBI $M 3 4 4 4 4 19
Partnership Contributions $M 1.5 2 2 2 2 9.5
Achieved 1.5 2 1.9 0.9 0 6.3
Remaining  0 0 0.1 1.1 2 3.2
Total $M  4.5 6 6 6 6 28.5

Funders Include

  • ALS Society of Essex County
  • Baycrest Foundation
  • Bruyère Research Institute
  • Campbell Foundation
  • Ontario Brain Institute
  • Providence Care
  • Queen’s University Department of Psychiatry
  • Robert Hegele
  • Shirley Colthart Research Fund
  • The Temerty Family Foundation
  • Thunder Bay Regional Health Sciences Centre
  • University of Ottawa
  • University of Ottawa Brain and Mind Research Institute

Acknowledgements 

Ontario Brain Institute Acknowledgement Statement

This research was conducted with the support of the Ontario Brain Institute, an independent non-profit corporation, funded partially by the Ontario government. The opinions, results and conclusions are those of the authors and no endorsement by the Ontario Brain Institute is intended or should be inferred.

Matching Funds Statement 

Matching funds were provided by participant hospital and research foundations, including the Baycrest Foundation, Bruyere Research Institute, Centre for Addiction and Mental Health Foundation, London Health Sciences Foundation,McMaster University Faculty of Health Sciences, Ottawa Brain and Mind Research Institute, Queen’s University Faculty of Health Sciences, the Thunder Bay Regional Heath Sciences Centre, the University of Ottawa Faculty of Medicine, and the Windsor/Essex County ALS Association.

The Temerty Family Foundation provided the major infrastructure matching funds.

D. Beaton and S. Strother are partly supported by a Canadian Institutes of Health Research (CIHR) grant (MOP201403).